177 related articles for article (PubMed ID: 12823617)
61. Defensins.
Ganz T; Lehrer RI
Curr Opin Immunol; 1994 Aug; 6(4):584-9. PubMed ID: 7946046
[TBL] [Abstract][Full Text] [Related]
62. Matrix metalloproteinase-7 activation of mouse paneth cell pro-alpha-defensins: SER43 down arrow ILE44 proteolysis enables membrane-disruptive activity.
Weeks CS; Tanabe H; Cummings JE; Crampton SP; Sheynis T; Jelinek R; Vanderlick TK; Cocco MJ; Ouellette AJ
J Biol Chem; 2006 Sep; 281(39):28932-42. PubMed ID: 16822871
[TBL] [Abstract][Full Text] [Related]
63. Antimicrobial activity of truncated alpha-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges.
Lundy FT; Nelson J; Lockhart D; Greer B; Harriott P; Marley JJ
Mol Immunol; 2008 Jan; 45(1):190-3. PubMed ID: 17548109
[TBL] [Abstract][Full Text] [Related]
64. A hybrid cationic peptide composed of human β-defensin-1 and humanized θ-defensin sequences exhibits salt-resistant antimicrobial activity.
Olli S; Nagaraj R; Motukupally SR
Antimicrob Agents Chemother; 2015 Jan; 59(1):217-25. PubMed ID: 25348533
[TBL] [Abstract][Full Text] [Related]
65. NMR studies of defensin antimicrobial peptides. 1. Resonance assignment and secondary structure determination of rabbit NP-2 and human HNP-1.
Zhang XL; Selsted ME; Pardi A
Biochemistry; 1992 Nov; 31(46):11348-56. PubMed ID: 1445872
[TBL] [Abstract][Full Text] [Related]
66. Solution structure and functional studies of the highly potent equine antimicrobial peptide DEFA1.
Michalek M; Jung S; Shomali MR; Cauchard S; Sönnichsen FD; Grötzinger J
Biochem Biophys Res Commun; 2015 Apr; 459(4):668-72. PubMed ID: 25769951
[TBL] [Abstract][Full Text] [Related]
67. Rat neutrophil defensins. Precursor structures and expression during neutrophilic myelopoiesis.
Yount NY; Wang MS; Yuan J; Banaiee N; Ouellette AJ; Selsted ME
J Immunol; 1995 Nov; 155(9):4476-84. PubMed ID: 7594610
[TBL] [Abstract][Full Text] [Related]
68. Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a complex with chymotrypsinogen and trypsin.
Elphick D; Liddell S; Mahida YR
Am J Pathol; 2008 Mar; 172(3):702-13. PubMed ID: 18258845
[TBL] [Abstract][Full Text] [Related]
69. Solution structure and activity of the synthetic four-disulfide bond Mediterranean mussel defensin (MGD-1).
Yang YS; Mitta G; Chavanieu A; Calas B; Sanchez JF; Roch P; Aumelas A
Biochemistry; 2000 Nov; 39(47):14436-47. PubMed ID: 11087396
[TBL] [Abstract][Full Text] [Related]
70. Delineation of interfaces on human alpha-defensins critical for human adenovirus and human papillomavirus inhibition.
Tenge VR; Gounder AP; Wiens ME; Lu W; Smith JG
PLoS Pathog; 2014 Sep; 10(9):e1004360. PubMed ID: 25188351
[TBL] [Abstract][Full Text] [Related]
71. Conformational landscape and pathway of disulfide bond reduction of human alpha defensin.
Snijder J; van de Waterbeemd M; Glover MS; Shi L; Clemmer DE; Heck AJ
Protein Sci; 2015 Aug; 24(8):1264-71. PubMed ID: 25970658
[TBL] [Abstract][Full Text] [Related]
72. Synthesis and characterization of defensin NP-1.
Rao AG; Rood T; Maddox J; Duvick J
Int J Pept Protein Res; 1992 Dec; 40(6):507-14. PubMed ID: 1286934
[TBL] [Abstract][Full Text] [Related]
73. The Defensins Consist of Two Independent, Convergent Protein Superfamilies.
Shafee TM; Lay FT; Hulett MD; Anderson MA
Mol Biol Evol; 2016 Sep; 33(9):2345-56. PubMed ID: 27297472
[TBL] [Abstract][Full Text] [Related]
74. Sometimes it takes two to tango: contributions of dimerization to functions of human α-defensin HNP1 peptide.
Pazgier M; Wei G; Ericksen B; Jung G; Wu Z; de Leeuw E; Yuan W; Szmacinski H; Lu WY; Lubkowski J; Lehrer RI; Lu W
J Biol Chem; 2012 Mar; 287(12):8944-53. PubMed ID: 22270360
[TBL] [Abstract][Full Text] [Related]
75. Arginine in α-defensins: differential effects on bactericidal activity correspond to geometry of membrane curvature generation and peptide-lipid phase behavior.
Schmidt NW; Tai KP; Kamdar K; Mishra A; Lai GH; Zhao K; Ouellette AJ; Wong GC
J Biol Chem; 2012 Jun; 287(26):21866-72. PubMed ID: 22566697
[TBL] [Abstract][Full Text] [Related]
76. Visualizing attack of Escherichia coli by the antimicrobial peptide human defensin 5.
Chileveru HR; Lim SA; Chairatana P; Wommack AJ; Chiang IL; Nolan EM
Biochemistry; 2015 Mar; 54(9):1767-77. PubMed ID: 25664683
[TBL] [Abstract][Full Text] [Related]
77. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation.
Groeneveld TW; Ramwadhdoebé TH; Trouw LA; van den Ham DL; van der Borden V; Drijfhout JW; Hiemstra PS; Daha MR; Roos A
Mol Immunol; 2007 Jul; 44(14):3608-14. PubMed ID: 17448537
[TBL] [Abstract][Full Text] [Related]
78. Trp-26 imparts functional versatility to human alpha-defensin HNP1.
Wei G; Pazgier M; de Leeuw E; Rajabi M; Li J; Zou G; Jung G; Yuan W; Lu WY; Lehrer RI; Lu W
J Biol Chem; 2010 May; 285(21):16275-85. PubMed ID: 20220136
[TBL] [Abstract][Full Text] [Related]
79. An insect defensin-derived β-hairpin peptide with enhanced antibacterial activity.
Gao B; Zhu S
ACS Chem Biol; 2014 Feb; 9(2):405-13. PubMed ID: 24228718
[TBL] [Abstract][Full Text] [Related]
80. Processing of Neutrophil α-Defensins Does Not Rely on Serine Proteases In Vivo.
Glenthøj A; Nickles K; Cowland J; Borregaard N
PLoS One; 2015; 10(5):e0125483. PubMed ID: 25945506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
